AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Arcturus Therapeutics Holdings Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00NNW8JL0
9.84▼ 0.89 (-8.29%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
10.73
Day's Range
9.75 – 10.69
52-Week Range
5.50 – 17.96
Volume
466.1K
Avg Volume
735.4K
Share Statistics
Shares Outstanding
Employees
111
Exchange
XNAS
Listed
2013-05-22
Share count as of August 4, 2026

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Arcturus Therapeutics Holdings Inc. Common Stock (ARCT)
What is Arcturus Therapeutics Holdings Inc. Common Stock's Market Cap?
Arcturus Therapeutics Holdings Inc. Common Stock's Market Cap is $279.7M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Price / Sales?
Arcturus Therapeutics Holdings Inc. Common Stock's Price / Sales is 9.5×, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Revenue (TTM)?
Arcturus Therapeutics Holdings Inc. Common Stock's Revenue (TTM) is $29.4M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM)?
Arcturus Therapeutics Holdings Inc. Common Stock's Net Income (TTM) is -$93.3M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA?
Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA is -$99.5M, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM)?
Arcturus Therapeutics Holdings Inc. Common Stock's Diluted EPS (TTM) is -3.28, based on as-reported figures from SEC (XBRL) filings.
What is Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin?
Arcturus Therapeutics Holdings Inc. Common Stock's EBITDA Margin is -339.0%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ARCTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue—
YoY growth-89.5%—-68.4%-58.8%
Operating expenses:
Research and development, net—
General and administrative—
Total operating expenses—
% of revenue963.3%—535.1%196.3%
Loss from operations—
% of revenue-863.3%—-435.1%-96.3%
Finance income, net—
Other expense———
Net loss before income taxes—
Net loss
% of revenue-803.8%—-404.1%-78.4%
Basic—
Diluted—